Home » Funding & investments » News Digest #197 – These Fifty Synthetic Biology Companies Raised $1.7B in 2017

News Digest #197 – These Fifty Synthetic Biology Companies Raised $1.7B in 2017



Hi all,

Given the record breaking amount of money being invested in synthetic biology companies, it seemed that 2016 was going to be hard for the industry to top. However, we just crunched the numbers for 2017 and thanks to several late mega-raises from both public and private companies, more than $1.7 billion was raised. See the charts below and check out the story here.

Flagship Pioneering closed a new $618M life science fund, GenScript announced that it has acquired CustomArray to expand its synthetic biology portfolio. GenScript also saw a sharp increase in its stock price after it announced a CAR-T Cell immunotherapy collaboration with Janssen. Thermo Fisher and Juno Therapeutics also announced a new CAR T Partnership. French company DEINOVE launched the production of its first carotenoid molecule.

From our blog, check out Leah Cannon’s article about why diversity matters in founding teams.

FREDsense Technologies recently closed a seed round. The Canadian company that spun out from an iGEM project is developing bacterial biosensors to detect chemicals in wastewater:

More exciting news from the field of cultured meat: SuperMeat, an Israeli biotech and food-tech startup, has raised $3M in seed funding to bring clean chicken products to market within three years.

Not bad for January 3rd!
Happy 2018!




Who’s Hiring?

Product Scientist: Opentrons, New York

Scientist, Synthetic Biology / Protein Engineering: Arzeda, Seattle, WA

BioBuilder Teaching Assistants

Senior Scientist, Enzyme Engineering: Amyris, Emeryville, California

Senior Scientist, Strain Engineering: Amyris, Emeryville, California

Scientist, Cytochrome P450 Engineering: Amyris, Emeryville, California

Scientist, Strain Performance Optimization, PD&E: Amyris, Emeryville, California

Senior Director, Separations Process Development: Amyris, Emeryville, California

Feature your job here, click here to contact us


Weizmann Institute Event in Israel: Synthetic Biology Applications for a Livable Future

Agricultural Bioscience Company Yield10 Bioscience Announces Closing of $14.5 Million Public Offering

In The Lab Of The Future, Robots Run Experiments While Scientists Sleep (Forbes)

Scientists Are Designing Artisanal Proteins for Your Body (The New York Times)

Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum

Innovation Drives Operational Challenges that Impact R&D Productivity (Science Exchange)

Copyright © %%current_year_YYYY%%, All rights reserved.

1547 Palos Verdes Mall, #411
Walnut Creek, CA 94597

About Us | Update Preferences | Unsubscribe | View email in your browser

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Editor’s picks